Cover story: AIPPI 2015, Rio de Janeiro
AIPPI is looking forward to welcoming delegates to the unforgettable Brazilian city of Rio de Janeiro for its World Congress.
What’s of interest in Europe?
CMS reviews interesting developments in Europe this year, looking at the current status of the Unified Patent Court, new standards for SEP injunctions and developments in Russian IP protection.
The clue is in the case law
Russian law provides for patent term extensions for pharma patents, but it is not always clear on the finer details. Evgeny Aleksanrov, Gorodissky & Partners, examines the case law.
Of rising importance
Pharmacokinetic patents are a valuable asset for innovative pharmaceutical companies to obtain in the US, as Clark Sullivan and Sujatha Vathyam, Troutman Sanders, explain.
The decision in JP Morgan Chase means that parties in US trials will need to think carefully about the timing of stay motions based on Covered Business Method Review proceedings, as Kenneth R. Adamo, Brent Ray, Eugene Goryunov, and Greg Polins of Kirkland Ellis LLP explain.
Find and share the knowledge: Brazil
Patent Knowledge Share focuses on Brazil, with Roberto Rodrigues of Licks Attorneys answering questions about patent litigation and management.
Don’t jeopardize your rights
The Controller General of Patents in India has made it clear that amendment of specification claims at the time of national phase PCT entry in India is not permitted, as Dr Mohan Dewan, R K Dewan & Co. (India), explains.
Hopes are renewed
The appointment of a new President at the Brazilian Patent and Trademark Office was announced in July. Tatiana Schuenck da Fonseca and Ana Paula Jardim of Luiz Leonardos set out the challenges he faces.
First impressions matter
Dr. Stefan Schohe, Boehmert & Boehmert, reviews two recent German cases that call for an in-depth analysis in matters of patent eligibility.
A promising economy
Hande Mumcuoglu, Halitligil and Ark Patent and Trademark Consultancy, investigates the growing interest in Turkey and IP protection in the country from foreign companies.
Thomas L. Lederer, Patent Attorney at Dennemeyer & Associates, explores the evolution of patentability of computer-implemented inventions.
End in sight for slipper patent fight!
Jeffrey M. Kaden of Gottlieb, Rackman and Reisman, reports on a US design patent and trade dress dispute that has dragged on for four years.
Enforcing use patents
The limited interpretation of linkage regulations for use patents means IP owners are looking to the Mexican courts. Alejandro Luna, Armando Arenas and Georgina Flores of Olivares explain the strategies they are using to aid their clients claims.
Harnessing the value of patent information can help shape corporate strategy and steer R&D efforts. Katy Wood, Minesoft, explores the options.
Validity of patent linkage across globe
Zoya Nafis and Divya Srinivasan of LexOrbis examine different approaches to patent linkage for drugs and medicines around the world and ask how long India can avoid recognizing the concept.
Accelerated information sharing
Diego G. Rossi and Marcelo Blanco, Iberbrand, explain the workings of the Mexican patent prosecution highway program.